Type
Closure
Country
United Kingdom
Region
Yorkshire and the Humber; East Riding and North Lincolnshire; North and North East Lincolnshire
Location of affected unit(s)
Grimsby
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.1 - Manufacture of basic pharmaceutical products

395 - 400 jobs
Number of planned job losses
Job loss
Announcement Date
25 September 2018
Employment effect (start)
Foreseen end date
31 December 2020

Description

Pharmaceutical company Novartis has announced plans to cut 400 jobs from its UK operations by closing its manufacturing plant in Grimsby. Additionally, it is reducing headcount in its home country of Switzerland by more than 2,000, as part of a global review of its business. As of October 2018, the company employs around 1,500 people in the UK across three sites including Grimsby. The job cuts in Grimsby will be phased over approximately a year and a half, with an end date at the end of 2020. A spokesperson for the company stressed that the decision was not linked to the UK's departure from the EU.


Sources

Citation

Eurofound (2018), Novartis, Closure in United Kingdom, factsheet number 95640, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/95640.